Searchable abstracts of presentations at key conferences in endocrinology

ea0011p521 | Endocrine tumours and neoplasia | ECE2006

Outcome of management of craniopharyngiomas – a contemporary series

Rippin JD , Mitchell RD , McGregor EJ , Toogood AA , Gittoes NJ

The optimum management of patients with craniopharyngiomas is controversial. Evidence relies on a small number of retrospective outcome surveys that encompass time periods that are not necessarily representative of current surgical techniques and imaging modalities. We have reviewed outcome in a more contemporary group of patients managed at a single centre.Case-notes and electronic data were reviewed of all patients treated for craniopharyngioma since 1...

ea0078OC7.2 | Oral Communications 7 | BSPED2021

Multi-centre service evaluation of presentation of newly diagnosed type 1 diabetes in children in the U.K. furing the COVID-19 pandemic

McLean Ross , Mitchell Rod , Sachdev Pooja , Conway Nicky , Liu Jo-Fen

Background: The COVID-19 pandemic led to major changes in the pattern of presentation to Emergency Departments. This prompted concern within Paediatrics that this altered behaviour could lead to delays in the diagnosis of life-threatening conditions such as type 1 diabetes. A multicentre study was conducted to determine the incidence, referral patterns and severity of disease at presentation of this condition. Methods: This was a U.K.-based multi-centre ...

ea0081ep805 | Pituitary and Neuroendocrinology | ECE2022

Endocrinopathy behind the facemask

Nyunt Sandhi , Avari Parizad , Tarigopula Giridhar , Martin Niamh , Mitchell Catherine , Ling Yong Yong

A 44-year-old gentleman presented to the Emergency Department with a 2-week history of fevers and rigors. Past medical history was unremarkable other than an earlier diagnosis of hypertension. He was noted to have new onset atrial fibrillation with rapid ventricular response, and a new diagnosis of hypertrophic obstructive cardiomyopathy (HOCM) was made on echocardiography. In addition, a vegetation was identified on the mitral valve. Treatment for infective endocarditis (Stre...

ea0050p272 | Neuroendocrinology and Pituitary | SFEBES2017

The severity of obstructive sleep apnoea does not influence ambient IGF-I levels

Lynch Julie , Kyriakakis Nikolaos , Elliott Mark , Ghosh Dipansu , Nix Mitchell , Watts Sue , Murray Robert D

Introduction: Obstructive sleep apnoea (OSA) is reported to have effects on a number of hormone systems including glycaemic control, catecholamines, and the HPA axis. In this study we aimed to determine the impact of OSA on IGF-I levels.Patients & Methods: This is a prospective cohort study performed at Leeds Teaching Hospitals. Patients were recruited from the Sleep Apnoea Clinic between November 2014 and May 2...

ea0050p396 | Thyroid | SFEBES2017

Association of a promoter BAFF polymorphism in Graves’ disease

Lane Laura C , Allinson Kathleen , Cordell Heather J , Mitchell Anna L , Pearce Simon

Introduction: B lymphocyte activating factor (BAFF), a member of the tumour necrosis factor family, is essential for B cell activation, differentiation and survival. It promotes autoantibody production and as Graves’ disease is caused by thyroid stimulating autoantibodies, it is an excellent functional candidate gene. Indeed, elevated serum BAFF levels have been found in patients with several autoimmune diseases, including Graves’ disease (GD). The T al...

ea0050p272 | Neuroendocrinology and Pituitary | SFEBES2017

The severity of obstructive sleep apnoea does not influence ambient IGF-I levels

Lynch Julie , Kyriakakis Nikolaos , Elliott Mark , Ghosh Dipansu , Nix Mitchell , Watts Sue , Murray Robert D

Introduction: Obstructive sleep apnoea (OSA) is reported to have effects on a number of hormone systems including glycaemic control, catecholamines, and the HPA axis. In this study we aimed to determine the impact of OSA on IGF-I levels.Patients & Methods: This is a prospective cohort study performed at Leeds Teaching Hospitals. Patients were recruited from the Sleep Apnoea Clinic between November 2014 and May 2...

ea0050p396 | Thyroid | SFEBES2017

Association of a promoter BAFF polymorphism in Graves’ disease

Lane Laura C , Allinson Kathleen , Cordell Heather J , Mitchell Anna L , Pearce Simon

Introduction: B lymphocyte activating factor (BAFF), a member of the tumour necrosis factor family, is essential for B cell activation, differentiation and survival. It promotes autoantibody production and as Graves’ disease is caused by thyroid stimulating autoantibodies, it is an excellent functional candidate gene. Indeed, elevated serum BAFF levels have been found in patients with several autoimmune diseases, including Graves’ disease (GD). The T al...

ea0082p6 | Poster Presentations | SFEEU2022

Endocrinopathy behind the facemask

Nyunt Sandhi , Avari Parizad , Tarigopula Giridhar , Mitchell Catherine , Yong Ling Yong , Martin Niamh

Case history: A 44-year-old gentleman presented to A&E with a 2-week history of fevers and rigors. He gave a background history of hypertension. He was noted to have new onset atrial fibrillation with rapid ventricular response, and a new diagnosis of hypertrophic obstructive cardiomyopathy (HOCM) was made on echocardiography. A vegetation identified on the mitral valve led to an unexpected diagnosis of infective endocarditis. Antibiotic treatment for infective endocarditi...

ea0082p10 | Poster Presentations | SFEEU2022

Familial hypocalciuric hypercalcaemia or multiple endocrine neoplasia 1? – when assay interference challenges the diagnosis

Vanderpant Natalie , D Boyle Luke , Bech Paul , Mitchell Catherine , Tan Tricia , Morganstein Daniel L

Case history: An asymptomatic 26-year-old female was found to have hypercalcaemia with an associated normal PTH and vitamin D deficiency on blood tests in primary care. She was referred to the endocrinology clinic for further assessment. There was no history of renal calculi, constipation or fractures. The patient was taking the combined oral contraceptive pill only. There was a family history of hypercalcaemia, with an uncle affected in his 50s and a first cousin in his 20s. ...

ea0086p1 | Adrenal and Cardiovascular | SFEBES2022

Replication of association at the LPP and UBASH3A loci in a UK autoimmune Addison’s disease cohort

Howarth Sophie , Sneddon Georgina , Allinson Kathleen , Razvi Salman , Mitchell Anna , Pearce Simon

Background: Autoimmune Addison’s disease (AAD) is a rare endocrinopathy arising from a complex interplay between multiple genetic susceptibility polymorphisms and environmental factors. Several variants in immune pathways have been identified through hypothesis-driven candidate gene analysis, though these associations can prove difficult to replicate. The first genome wide association study (GWAS) with patients from Scandinavian Addison’s registries identified associ...